Research and Development of Novel Drug Delivery Systems Symposium
Research and Development of Novel Drug Delivery Systems Symposium
批准号:
8907150
负责人:
Ram I. Mahato
金额:
$0.8万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2016-03-31
关键词:
AcademiaAddressAreaAwardBiological ProductsClinicClinicalCommunitiesDevelopmentDosage FormsDose-LimitingDrug Delivery SystemsDrug FormulationsDrug IndustryEvaluationFeesFinancial SupportFundingFunding OpportunitiesHourIndividualIndustryKnowledgeManuscriptsMedical centerMinorityMinority ParticipationMolecular BiologyNanotechnologyNebraskaNucleic AcidsOralPharmaceutical PreparationsPharmacologic SubstancePharmacotherapyPolymersPostdoctoral FellowPropertyPublicationsResearchResearch PersonnelResistanceReview CommitteeRoleScienceScientistStagingStudentsSystemTechnologyTherapeutic AgentsTranslationsTravelUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesWorkabstractingbasebench to bedsidecandidate selectioncareerdesigndrug candidatedrug developmentdrug discoverygraduate studenthigh throughput screeningindexingmedical schoolsmultidisciplinarynanomedicinenew therapeutic targetnovelnovel therapeuticspostersproduct developmentprofessorpublic health relevanceresearch and developmentscale upsmall moleculesymposiumtargeted deliverytoolundergraduate studentwaiver
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): High throughput screening and emergence of new therapeutic targets led to discovery of highly potent molecules with nanomolar efficacy. Clinical translation of the new therapeutic agents is limited by poor physicochemical and biopharmaceutical properties. To resolve this potential challenge, the need of the hour is the concerted effort by academia, pharmaceutical industry and regulatory body towards the development of novel delivery systems. Several new drug therapies fail due to non- selective drug disposition, poor accessibility to intracellular targets, dose limiting off target effects and
resistance upon prolonged administration. These limitations can be potentially overcome through the development and scale up of novel drug delivery technologies. To expedite the translation of new molecules, the purpose of this conference is to share knowledge on drug product development principles among key players of pharmaceutical drug development, including representatives from academia, industry, and regulatory agencies. Participation from a diverse group of individuals including those representing minorities and traditionally underrepresented communities in science careers is expected. The two day symposium will include oral as well as poster presentations. Financial support provided for this conference will create opportunity to students to interact with top scientist in the field of drug delivery. In addition, registration fee waivers and travel awards will be provided to encourage participation by minorities and underrepresented communities. Based on the presentations and discussions at the conference, a manuscript will be prepared within 3 months after the conference and submitted for publication in a timely manner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice
-
批准号:10639037
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2023
-
负责人:Ram I. Mahato
-
依托单位:
Insight into the mechanism of action of the SSB interactome
-
批准号:10574583
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2022
-
负责人:Ram I. Mahato
-
依托单位:
Lipid nanomedicine targeting multiple signaling pathways of medulloblastoma
-
批准号:10663377
-
项目类别:
-
资助金额:$47.56万
-
财政年份:2022
-
负责人:Ram I. Mahato
-
依托单位:
Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer
-
批准号:10346555
-
项目类别:
-
资助金额:$45.47万
-
财政年份:2022
-
负责人:Ram I. Mahato
-
依托单位:
Lipid nanomedicine targeting multiple signaling pathways of medulloblastoma
-
批准号:10504006
-
项目类别:
-
资助金额:$48.9万
-
财政年份:2022
-
负责人:Ram I. Mahato
-
依托单位:
Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer
-
批准号:10555244
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2022
-
负责人:Ram I. Mahato
-
依托单位:
Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc
-
批准号:9298650
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2014
-
负责人:Ram I. Mahato
-
依托单位:
Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc
-
批准号:8761405
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2014
-
负责人:Ram I. Mahato
-
依托单位:
Targeted Delivery of TFOs for Treatment of Liver Fibrosis
-
批准号:7212732
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2007
-
负责人:Ram I. Mahato
-
依托单位:
Targeted Delivery of TFOs for Treatment of Liver Fibrosis
-
批准号:7359615
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2007
-
负责人:Ram I. Mahato
-
依托单位:
Targeted Delivery of TFOs for Treatment of Liver Fibrosis
-
批准号:7564713
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2007
-
负责人:Ram I. Mahato
-
依托单位:
Targeted Delivery of TFOs for Treatment of Liver Fibrosis
-
批准号:7747940
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2007
-
负责人:Ram I. Mahato
-
依托单位:
Growth Factor and Antiapoptotic Gene Delivery to Human Islets
-
批准号:8081214
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2005
-
负责人:Ram I. Mahato
-
依托单位:
Growth Factor and Antiapoptotic Gene Delivery to Human Islets
-
批准号:6965777
-
项目类别:
-
资助金额:$25.7万
-
财政年份:2005
-
负责人:Ram I. Mahato
-
依托单位:
Growth Factor and Antiapoptotic Gene Delivery to Human Islets
-
批准号:7095279
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2005
-
负责人:Ram I. Mahato
-
依托单位:
Growth Factor and Antiapoptotic Gene Delivery to Human Islets
-
批准号:7418614
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2005
-
负责人:Ram I. Mahato
-
依托单位:
Growth Factor and Antiapoptotic Gene Delivery to Human Islets
-
批准号:8278061
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2005
-
负责人:Ram I. Mahato
-
依托单位:
Growth Factor and Antiapoptotic Gene Delivery to Human Islets
-
批准号:7228473
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2005
-
负责人:Ram I. Mahato
-
依托单位:
Growth Factor and Antiapoptotic Gene Delivery to Human Islets
-
批准号:7696902
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2005
-
负责人:Ram I. Mahato
-
依托单位:
海外基金